Dharwad-based Shilpa Biologicals Private Limited (SBPL) will manufacture Sputnik V vaccine at its production centre in Belur Industrial Area, near Dharwad.
It will be among the first production units of the Russian vaccine in India.
SBPL is an arm of Shilpa Medicare, one of the top suppliers of drugs in the country, established in 1987 in Raichur.
Sputnik V has been developed by the Gamaleya National Research Institute of Epidemiology and Microbiology of Russia.
Indian pharmaceutical company Dr Reddy’s Laboratory entered into a partnership with Russian Direct Investment Fund for the vaccine in India.